DLH Holdings Corp delivers health and readiness solutions for federal government customers through digital transformation and cyber security, science research and development, and systems engineering and integration... Show more
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| XTAP | 46.85 | 0.55 | +1.19% |
| Innovator U.S. Equity Accelerated Plus ETF (XTAP) | |||
| HEFT | 25.90 | 0.07 | +0.27% |
| Hedgeye Fourth Turning ETF | |||
| TYYY | 40.25 | N/A | N/A |
| XETFs Tsla Daily Income ETF | |||
| WINN | 32.49 | -0.15 | -0.46% |
| Harbor Long-Term Growers ETF (WINN) | |||
| RLTY | 14.77 | -0.14 | -0.94% |
| Cohen & Steers Real Estate Opportunities and Income Fund | |||
A.I.dvisor indicates that over the last year, DLHC has been loosely correlated with RGP. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if DLHC jumps, then RGP could also see price increases.
| Ticker / NAME | Correlation To DLHC | 1D Price Change % | ||
|---|---|---|---|---|
| DLHC | 100% | -0.27% | ||
| RGP - DLHC | 38% Loosely correlated | +2.59% | ||
| GHC - DLHC | 36% Loosely correlated | +0.53% | ||
| MSA - DLHC | 35% Loosely correlated | +1.25% | ||
| FORR - DLHC | 33% Poorly correlated | -1.12% | ||
| FC - DLHC | 31% Poorly correlated | -4.26% | ||
More | ||||
| Ticker / NAME | Correlation To DLHC | 1D Price Change % |
|---|---|---|
| DLHC | 100% | -0.27% |
| Office Equipment/Supplies industry (45 stocks) | -12% Poorly correlated | -0.99% |
| Producer Manufacturing industry (346 stocks) | -15% Poorly correlated | +0.99% |
a provider of healthcare, logistics and technical support services
Industry OfficeEquipmentSupplies
The Aroon Indicator for DLHC entered a downward trend on November 10, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 305 similar instances where the Aroon Indicator formed such a pattern. In 226 of the 305 cases the stock moved lower. This puts the odds of a downward move at 74%.
DLHC moved below its 50-day moving average on October 12, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where DLHC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 71%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 43 of 65 cases where DLHC's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 66%.
The Momentum Indicator moved above the 0 level on November 09, 2026. You may want to consider a long position or call options on DLHC as a result. In 71 of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 76%.
The Moving Average Convergence Divergence (MACD) for DLHC just turned positive on November 09, 2026. Looking at past instances where DLHC's MACD turned positive, the stock continued to rise in 39 of 54 cases over the following month. The odds of a continued upward trend are 72%.
Following a +1.94% 3-day Advance, the price is estimated to grow further. Considering data from situations where DLHC advanced for three days, in 193 of 269 cases, the price rose further within the following month. The odds of a continued upward trend are 72%.
The Tickeron Valuation Rating of 39 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.561) is normal, around the industry mean (5.887). P/E Ratio (-2.423) is within average values for comparable stocks, (33.618). Projected Growth (PEG Ratio) (1.220) is also within normal values, averaging (1.946). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (0.228) is also within normal values, averaging (9.907).
The Tickeron Price Growth Rating for this company is 78 (best 1 - 100 worst), indicating slightly worse than average price growth. DLHC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DLHC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.